JP Patent

JP5989965B2 — ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩

Assigned to Merck Sharp and Dohme LLC · Expires 2016-09-07 · 10y expired

What this patent protects

Patent listed against rucaparib-camsylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP5989965B2
Jurisdiction
JP
Classification
—
Expires
2016-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.